205 related articles for article (PubMed ID: 17537308)
21. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines.
Lee CM; Fuhrman CB; Planelles V; Peltier MR; Gaffney DK; Soisson AP; Dodson MK; Tolley HD; Green CL; Zempolich KA
Clin Cancer Res; 2006 Jan; 12(1):250-6. PubMed ID: 16397049
[TBL] [Abstract][Full Text] [Related]
22. Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma.
Hu L; Hofmann J; Jaffe RB
Clin Cancer Res; 2005 Nov; 11(22):8208-12. PubMed ID: 16299254
[TBL] [Abstract][Full Text] [Related]
23. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
Zhang HY; Zhang PN; Sun H
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
[TBL] [Abstract][Full Text] [Related]
26. [Effect and mechanism of endoplasmic reticulum stress on cisplatin resistance in ovarian carcinoma].
Tian J; Hu X; Qu Q
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):324-8. PubMed ID: 25030585
[TBL] [Abstract][Full Text] [Related]
27. [Effect and mechanism of LY294002 on growth of fibrosarcoma cell line HT1080].
Zhou H; Huang XY; Yang T; Wang T; Xu D; Wen FQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):20-3. PubMed ID: 20369463
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma.
Semba S; Itoh N; Ito M; Youssef EM; Harada M; Moriya T; Kimura W; Yamakawa M
Clin Cancer Res; 2002 Dec; 8(12):3824-31. PubMed ID: 12473596
[TBL] [Abstract][Full Text] [Related]
29. Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer.
Zhang XY; Zhang HY; Zhang PN; Lu X; Sun H
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):237-44. PubMed ID: 18395956
[TBL] [Abstract][Full Text] [Related]
30. [Activation of phosphatidylinositol 3-kinase-protein kinase B (PI3K-PKB) induced by 17beta-estradiol in endometrial carcinoma cell (Ishikawa)].
Guo RX; Wei LH; Wang JL; Sun PM; Sun XL
Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):469-73. PubMed ID: 15347471
[TBL] [Abstract][Full Text] [Related]
31. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
Nonaka M; Itamochi H; Kawaguchi W; Kudoh A; Sato S; Uegaki K; Naniwa J; Sato S; Shimada M; Oishi T; Terakawa N; Kigawa J; Harada T
Int J Gynecol Cancer; 2012 Jul; 22(6):922-9. PubMed ID: 22672985
[TBL] [Abstract][Full Text] [Related]
32. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway.
Li GQ; Xie J; Lei XY; Zhang L
World J Gastroenterol; 2009 Nov; 15(44):5541-8. PubMed ID: 19938192
[TBL] [Abstract][Full Text] [Related]
33. [Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms].
Wu HJ; Wu HT; Weng DH; Xing H; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):612-6. PubMed ID: 17983517
[TBL] [Abstract][Full Text] [Related]
34. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
35. [Effect of norcantharidin's derivative Nd3 on proliferation of human ovarian cancer cell line SKOV3 and its possible mechanisms].
Cao JH; Xu B; Li M; Wu DZ; Huang W; Cui JR
Ai Zheng; 2007 Apr; 26(4):361-6. PubMed ID: 17430652
[TBL] [Abstract][Full Text] [Related]
36. Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells.
Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
Cancer Res; 2003 Jul; 63(14):4044-7. PubMed ID: 12874004
[TBL] [Abstract][Full Text] [Related]
37. [Relation of ME491/CD63 gene and integrin alpha5 in the invasion and metastases of ovarian cancer].
Xia ZJ; Zhang SL; Zhou Z
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):765-9. PubMed ID: 16324252
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer.
Tomizawa M; Shinozaki F; Sugiyama T; Yamamoto S; Sueishi M; Yoshida T
World J Gastroenterol; 2010 Apr; 16(15):1854-8. PubMed ID: 20397262
[TBL] [Abstract][Full Text] [Related]
39. [Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study].
Jin P; Wang YH; Peng YG; Hu S; Lu Q; Yang LY
Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1068-75. PubMed ID: 21348195
[TBL] [Abstract][Full Text] [Related]
40. [Growth inhibition of combined pathway inhibitors on KRAS mutated non-small cell lung cancer cell line].
Li ZW; Yang ZL; Feng HL; Bian XC; Liu YY; Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):330-5. PubMed ID: 24004591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
